China Medical System Holdings (HKSE:00867) Interest Expense : HK$-51 Mil (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is China Medical System Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. China Medical System Holdings's interest expense for the six months ended in Dec. 2023 was HK$ -27 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-51 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. China Medical System Holdings's Operating Income for the six months ended in Dec. 2023 was HK$ 1,049 Mil. China Medical System Holdings's Interest Expense for the six months ended in Dec. 2023 was HK$ -27 Mil. China Medical System Holdings's Interest Coverage for the quarter that ended in Dec. 2023 was 38.30. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

China Medical System Holdings Interest Expense Historical Data

The historical data trend for China Medical System Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical System Holdings Interest Expense Chart

China Medical System Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-62.60

-32.62

-34.62

-54.82

-50.59

China Medical System Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-25.72	-21.23	-34.59	-23.20	-27.39

China Medical System Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-51 Mil.

China Medical System Holdings (HKSE:00867) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

China Medical System Holdings's Interest Expense for the six months ended in Dec. 2023 was HK$-27 Mil. Its Operating Income for the six months ended in Dec. 2023 was HK$1,049 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was HK$18 Mil.

China Medical System Holdings's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	1049.079	/	-27.392
	=	38.30

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. China Medical System Holdings Ltd has enough cash to cover all of its debt. Its financial situation is stable.

China Medical System Holdings (HKSE:00867) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (HKSE:00867) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

2M7C:Germany

Address

510 King’s Road, Unit 2106, 21st Floor, North Point, Island Place Tower, Hong Kong, HKG

Website

http://www.cms.net.cn

China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.

Executives

Treasure Sea Limited	2101 Beneficial owner
Lam Kong	2201 Interest of corporation controlled by you

China Medical System Holdings (HKSE:00867) Headlines

No Headlines